Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma

The progression of non-alcoholic fatty liver disease (NAFLD), the most common liver disease, leads to non-alcoholic steatohepatitis and hepatocellular carcinoma. Despite the increasing incidence and prevalence of NAFLD, its therapeutic and preventive strategies to lower the disease burden is limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Seogsong, Shin, Woo-Young, Oh, Yun Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069645/
https://www.ncbi.nlm.nih.gov/pubmed/37020584
http://dx.doi.org/10.3389/fendo.2023.1150360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069645/
https://www.ncbi.nlm.nih.gov/pubmed/37020584
http://dx.doi.org/10.3389/fendo.2023.1150360

Ejemplares similares